Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Brexit and the pharmaceutical industry: what happens if there’s no deal?

The pharmaceutical industry has voiced its increasing concerns about the possibility of no-deal Brexit when the UK leaves the EU in March next year, and what effect this will have on the industry and the supply of medicines to patients. In response, the UK Government announced a range of advice on batch testing, safety and quality of blood and organ products, as well as the marketing authorisation of drugs and regulation of clinical trials.


Go Top